169 related articles for article (PubMed ID: 23780840)
1. Development of a fluorescent monoclonal antibody-based assay to measure the allosteric effects of synthetic peptides on self-oligomerization of AGR2 protein.
Gray TA; Murray E; Nowicki MW; Remnant L; Scherl A; Muller P; Vojtesek B; Hupp TR
Protein Sci; 2013 Sep; 22(9):1266-78. PubMed ID: 23780840
[TBL] [Abstract][Full Text] [Related]
2. A divergent substrate-binding loop within the pro-oncogenic protein anterior gradient-2 forms a docking site for Reptin.
Maslon MM; Hrstka R; Vojtesek B; Hupp TR
J Mol Biol; 2010 Dec; 404(3):418-38. PubMed ID: 20888340
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry analysis of the oxidation states of the pro-oncogenic protein anterior gradient-2 reveals covalent dimerization via an intermolecular disulphide bond.
Clarke DJ; Murray E; Faktor J; Mohtar A; Vojtesek B; MacKay CL; Smith PL; Hupp TR
Biochim Biophys Acta; 2016 May; 1864(5):551-61. PubMed ID: 26876500
[TBL] [Abstract][Full Text] [Related]
4. An inter-subunit protein-peptide interface that stabilizes the specific activity and oligomerization of the AAA+ chaperone Reptin.
Coufalova D; Remnant L; Hernychova L; Muller P; Healy A; Kannan S; Westwood N; Verma CS; Vojtesek B; Hupp TR; Houston DR
J Proteomics; 2019 May; 199():89-101. PubMed ID: 30862565
[TBL] [Abstract][Full Text] [Related]
5. Reptin and Pontin oligomerization and activity are modulated through histone H3 N-terminal tail interaction.
Queval R; Papin C; Dalvai M; Bystricky K; Humbert O
J Biol Chem; 2014 Dec; 289(49):33999-4012. PubMed ID: 25336637
[TBL] [Abstract][Full Text] [Related]
6. AGR2-AGR3 hetero-oligomeric complexes: Identification and characterization.
Černocká H; Vonka P; Kasalová V; Sommerova L; Vandova V; Hrstka R; Ostatna V
Bioelectrochemistry; 2021 Aug; 140():107808. PubMed ID: 33848875
[TBL] [Abstract][Full Text] [Related]
7. The Sequence-specific Peptide-binding Activity of the Protein Sulfide Isomerase AGR2 Directs Its Stable Binding to the Oncogenic Receptor EpCAM.
Mohtar MA; Hernychova L; O'Neill JR; Lawrence ML; Murray E; Vojtesek B; Hupp TR
Mol Cell Proteomics; 2018 Apr; 17(4):737-763. PubMed ID: 29339412
[TBL] [Abstract][Full Text] [Related]
8. Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
Gray TA; MacLaine NJ; Michie CO; Bouchalova P; Murray E; Howie J; Hrstka R; Maslon MM; Nenutil R; Vojtesek B; Langdon S; Hayward L; Gourley C; Hupp TR
J Immunol Methods; 2012 Apr; 378(1-2):20-32. PubMed ID: 22361111
[TBL] [Abstract][Full Text] [Related]
9. Identification, characterization and application of a G-quadruplex structured DNA aptamer against cancer biomarker protein anterior gradient homolog 2.
Wu J; Wang C; Li X; Song Y; Wang W; Li C; Hu J; Zhu Z; Li J; Zhang W; Lu Z; Yang CJ
PLoS One; 2012; 7(9):e46393. PubMed ID: 23029506
[TBL] [Abstract][Full Text] [Related]
10. An Ultrasensitive Biosensor for Detection of Femtogram Levels of the Cancer Antigen AGR2 Using Monoclonal Antibody Modified Screen-Printed Gold Electrodes.
Białobrzeska W; Dziąbowska K; Lisowska M; Mohtar MA; Muller P; Vojtesek B; Krejcir R; O'Neill R; Hupp TR; Malinowska N; Bięga E; Bigus D; Cebula Z; Pala K; Czaczyk E; Żołędowska S; Nidzworski D
Biosensors (Basel); 2021 Jun; 11(6):. PubMed ID: 34200338
[TBL] [Abstract][Full Text] [Related]
11. Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammation.
Maurel M; Obacz J; Avril T; Ding YP; Papadodima O; Treton X; Daniel F; Pilalis E; Hörberg J; Hou W; Beauchamp MC; Tourneur-Marsille J; Cazals-Hatem D; Sommerova L; Samali A; Tavernier J; Hrstka R; Dupont A; Fessart D; Delom F; Fernandez-Zapico ME; Jansen G; Eriksson LA; Thomas DY; Jerome-Majewska L; Hupp T; Chatziioannou A; Chevet E; Ogier-Denis E
EMBO Mol Med; 2019 Jun; 11(6):. PubMed ID: 31040128
[TBL] [Abstract][Full Text] [Related]
12. A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum.
Shi T; Gao Y; Quek SI; Fillmore TL; Nicora CD; Su D; Zhao R; Kagan J; Srivastava S; Rodland KD; Liu T; Smith RD; Chan DW; Camp DG; Liu AY; Qian WJ
J Proteome Res; 2014 Feb; 13(2):875-82. PubMed ID: 24251762
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel HLA-A*0201-restricted epitopes from anterior gradient-2 as a tumor-associated antigen against colorectal cancer.
Lee HJ; Hong CY; Jin CJ; Kim MH; Lee YK; Nguyen-Pham TN; Lee H; Park BC; Chung IJ; Kim HJ; Lee JJ
Cell Mol Immunol; 2012 Mar; 9(2):175-83. PubMed ID: 22231555
[TBL] [Abstract][Full Text] [Related]
14. Elucidation of the AGR2 Interactome in Esophageal Adenocarcinoma Cells Identifies a Redox-Sensitive Chaperone Hub for the Quality Control of MUC-5AC.
Worfolk JC; Bell S; Simpson LD; Carne NA; Francis SL; Engelbertsen V; Brown AP; Walker J; Viswanath YK; Benham AM
Antioxid Redox Signal; 2019 Nov; 31(15):1117-1132. PubMed ID: 31436131
[No Abstract] [Full Text] [Related]
15. Development of an ELISA to detect the secreted prostate cancer biomarker AGR2 in voided urine.
Wayner EA; Quek SI; Ahmad R; Ho ME; Loprieno MA; Zhou Y; Ellis WJ; True LD; Liu AY
Prostate; 2012 Jun; 72(9):1023-34. PubMed ID: 22072305
[TBL] [Abstract][Full Text] [Related]
16. Ligand-regulated oligomerisation of allosterically interacting proteins.
Schaefer C; de Bruijn RAJ; McLeish TCB
Soft Matter; 2018 Aug; 14(34):6961-6968. PubMed ID: 30009315
[TBL] [Abstract][Full Text] [Related]
17. Binding of anterior gradient 2 and estrogen receptor-α: Dual critical roles in enhancing fulvestrant resistance and IGF-1-induced tumorigenesis of breast cancer.
Li Z; Zhu Q; Chen H; Hu L; Negi H; Zheng Y; Ahmed Y; Wu Z; Li D
Cancer Lett; 2016 Jul; 377(1):32-43. PubMed ID: 27063095
[TBL] [Abstract][Full Text] [Related]
18. Evidence for allosteric effects on p53 oligomerization induced by phosphorylation.
Muller P; Chan JM; Simoncik O; Fojta M; Lane DP; Hupp T; Vojtesek B
Protein Sci; 2018 Feb; 27(2):523-530. PubMed ID: 29124793
[TBL] [Abstract][Full Text] [Related]
19. Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization.
Guo H; Zhu Q; Yu X; Merugu SB; Mangukiya HB; Smith N; Li Z; Zhang B; Negi H; Rong R; Cheng K; Wu Z; Li D
Oncogene; 2017 Sep; 36(36):5098-5109. PubMed ID: 28481872
[TBL] [Abstract][Full Text] [Related]
20. Mutually exclusive binding of APPL(PH) to BAR domain and Reptin regulates β-catenin dependent transcriptional events.
Rashid S; Parveen Z; Ferdous S; Bibi N
Comput Biol Chem; 2013 Dec; 47():48-55. PubMed ID: 23891720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
